rs563112904
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_178034.4(PLA2G4D):c.387+14T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.37 ( 0 hom., cov: 0)
Exomes 𝑓: 0.42 ( 2127 hom. )
Failed GnomAD Quality Control
Consequence
PLA2G4D
NM_178034.4 intron
NM_178034.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.436
Publications
0 publications found
Genes affected
PLA2G4D (HGNC:30038): (phospholipase A2 group IVD) The phospholipase A2 enzyme family, including PLA2G4D, catalyze the hydrolysis of glycerophospholipids at the sn-2 position and then liberate free fatty acids and lysophospholipids (Chiba et al., 2004 [PubMed 14709560]).[supplied by OMIM, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 15-42086199-A-C is Benign according to our data. Variant chr15-42086199-A-C is described in ClinVar as Benign. ClinVar VariationId is 403315.Status of the report is criteria_provided_single_submitter, 1 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_178034.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PLA2G4D | NM_178034.4 | MANE Select | c.387+14T>G | intron | N/A | NP_828848.3 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PLA2G4D | ENST00000290472.4 | TSL:1 MANE Select | c.387+14T>G | intron | N/A | ENSP00000290472.3 |
Frequencies
GnomAD3 genomes AF: 0.372 AC: 21101AN: 56670Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
21101
AN:
56670
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.471 AC: 27614AN: 58584 AF XY: 0.475 show subpopulations
GnomAD2 exomes
AF:
AC:
27614
AN:
58584
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.424 AC: 69095AN: 162910Hom.: 2127 Cov.: 0 AF XY: 0.431 AC XY: 38297AN XY: 88826 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
69095
AN:
162910
Hom.:
Cov.:
0
AF XY:
AC XY:
38297
AN XY:
88826
show subpopulations
African (AFR)
AF:
AC:
1293
AN:
3086
American (AMR)
AF:
AC:
5520
AN:
10166
Ashkenazi Jewish (ASJ)
AF:
AC:
2100
AN:
4232
East Asian (EAS)
AF:
AC:
1965
AN:
4692
South Asian (SAS)
AF:
AC:
12905
AN:
27350
European-Finnish (FIN)
AF:
AC:
5341
AN:
11228
Middle Eastern (MID)
AF:
AC:
248
AN:
554
European-Non Finnish (NFE)
AF:
AC:
36637
AN:
94414
Other (OTH)
AF:
AC:
3086
AN:
7188
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
2618
5237
7855
10474
13092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff AF: 0.372 AC: 21104AN: 56690Hom.: 0 Cov.: 0 AF XY: 0.351 AC XY: 9251AN XY: 26354 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
AC:
21104
AN:
56690
Hom.:
Cov.:
0
AF XY:
AC XY:
9251
AN XY:
26354
show subpopulations
African (AFR)
AF:
AC:
5512
AN:
15386
American (AMR)
AF:
AC:
1700
AN:
5550
Ashkenazi Jewish (ASJ)
AF:
AC:
531
AN:
1288
East Asian (EAS)
AF:
AC:
441
AN:
1262
South Asian (SAS)
AF:
AC:
346
AN:
1022
European-Finnish (FIN)
AF:
AC:
537
AN:
3058
Middle Eastern (MID)
AF:
AC:
24
AN:
70
European-Non Finnish (NFE)
AF:
AC:
11589
AN:
27942
Other (OTH)
AF:
AC:
292
AN:
786
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.401
Heterozygous variant carriers
0
903
1806
2709
3612
4515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions as Germline
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.